CervoMed CRVO
NASDAQ CRVO
$1.39 +0.02 (+1.46%)
As of: Nov 11, 2026 · 9:35 AM EST

CervoMed (CRVO) Preferred Stock Liabilities (2022 - 2023)

Updated

CervoMed (CRVO) posted Preferred Stock Liabilities of $24.29 million for Q4 2022.

Analysis

CervoMed (CRVO) Preferred Stock Liabilities (2022 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 CervoMed 20.73 Mn -57.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 24.29 Mn
Mar 31, 2023 3.33 Mn
Dec 31, 2022 24.29 Mn
API Access

CervoMed Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=CRVO&period=max&api_key=YOUR_API_KEY